Panel Commentary: Clinical, Training and Knowledge Exchange Implications

Linda Sibley Executive Director Thames Valley Addiction Services, Suite 200–256 Pall Mall Street, London, Ontario, N6A 5P6 Christine Bois Priority Coordinator, Concurrent Disorders Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario, M5S 2S1 David Ross Coordinator of Professi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of mental health and addiction 2010-07, Vol.8 (3), p.518-524
1. Verfasser: Rush, Brian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Linda Sibley Executive Director Thames Valley Addiction Services, Suite 200–256 Pall Mall Street, London, Ontario, N6A 5P6 Christine Bois Priority Coordinator, Concurrent Disorders Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario, M5S 2S1 David Ross Coordinator of Professional Services Pavillon Foster, 3285, Boulevard Cavendish, Montréal, Québec, H4B 2L9 Dale Butterill Manager, Knowledge Transfer Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario, M5S 2S1 Panel Commentary Linda Sibley We have covered a tremendous amount of ground over 2 days and a lot has been said. When we do pilot studies I think we need to “work with the willing”; we need to go to our business relationships, go to people who are usually willing to try to implement new processes because it is a tremendous amount of work in very busy schedules to try new screening tools, outcome measures and track something differently. [...]even as one of the early converts for the Ontario standardized assessment tool initiative, one of the things that happened within my own local treatment system, and our agency, was the way that we deliver our programs. Because we had new tools, a lot of things changed to the process that clients follow from the front door in the waiting room through into the back of the agency where the clinical offices are. [...]when you bring new things in like a mental health screener at what point would we administer that; what will it do to the other people in the group, for example.
ISSN:1557-1874
1557-1882
DOI:10.1007/s11469-007-9105-5